GlassScriptPhysician profile
Jason Kehrer
NPI 1710114616
$26,718.86
in general payments reported to CMS, 2019-2025
18 companies · $557 in 2025
The $557 reported for 2025 was more than what 77% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $7,254 · 2024: $19K · 2025: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Consulting Fee: $4,050 · Food and Beverage: $2,281 · Travel and Lodging: $2,106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,281.25 |
| Consulting Fee | $4,050.00 |
| Food and Beverage | $2,281.29 |
| Travel and Lodging | $2,106.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $18,281.25 | 2024 | |
| Palette Life Sciences, INC. | $6,715.31 | 2023 | |
| Myriad Genetic Laboratories, INC. | $318.13 | 2023-2025 | Prolaris, Myrisk |
| Abbvie INC. | $175.74 | 2023-2024 | |
| Telix Pharmaceuticals | $172.66 | 2024-2025 | Illuccix |
| Boston Scientific Corporation | $124.39 | 2023-2025 | Spaceoar Vue System - 10ml, Spaceoar System |
| Sun Pharmaceutical Industries INC. | $120.33 | 2024-2025 | |
| Siemens Medical Solutions USA, INC. | $114.17 | 2024 | Varian Ethos Treatment Planning, Truebeam |
| Accord Healthcare, INC. | $113.77 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $106.87 | 2023-2025 | Orgovyx |
| Regeneron Healthcare Solutions, INC. | $98.17 | 2024-2025 | Libtayo |
| Elekta, INC. | $79.53 | 2023 | Elekta Medical Linear Accelerator |
| Progenics Pharmaceuticals, INC. | $69.06 | 2023-2025 | Pylarify |
| Merck Sharp & Dohme LLC | $67.16 | 2024-2025 | Lynparza, Keytruda |
| Bayer Healthcare Pharmaceuticals INC. | $63.02 | 2023-2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $54.39 | 2025 | |
| Blue Earth Diagnostics | $24.39 | 2024 | |
| Tactile Systems Technology INC | $20.52 | 2024 | Flexitouch Plus, Entre Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Kehrer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.